BJ

Bhavik Jain

Active Director Director DIN 06843157
DIN 06843157 First appointment Jul 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Total affiliations 5 Since Jul 2014
Shareholding value •••• Premium profile

About Bhavik Jain

Data last updated:

Bhavik Jain is a Director at Fitwel Pharmaceuticals Private Limited (since 2014), Director at Gelmek Healthcare Private Limited (since 2018) and Designated Partner at Eurus Lifesciences Llp (since 2017), and holds 2 more current directorships. The companies operate in Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹36.38 Cr; the largest is Fitwel Pharmaceuticals Private Limited at ₹25.09 Cr (FY 2025).

DIN 06843157
Primary Designation Director
Industry Pharma
First Appointment 15 Jul 2014
Oldest Company Age 12 yrs
Largest company Fitwel Pharmaceuticals Private Limited · ₹25.09 Cr (FY 2025)
Combined revenue ₹36.38 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jul 20142014₹25.09 Cr (FY 2025)Active
Gelmek Healthcare Private Limited U24304GJ2018PTC104041
Director11 Sep 20182018₹9.92 Cr (FY 2025)Active
Designated Partner08 Dec 20172017₹1.37 Cr (FY 2021)Active
Favion Healthcare Private Limited U46497GJ2025PTC162126
Director25 Apr 20252025Active
Director04 Jul 20242024Active

Directorship timeline

Open interactive timeline →
Eurus Lifesciences Llp
Fitwel Pharmaceuticals Private Limited
Gelmek Healthcare Private Limited
Euraphor Lifesciences Private Limited
Premium access

Shareholding and investment profile for Bhavik Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhavik Jain

Bhavik Jain currently holds 5 directorships: Fitwel Pharmaceuticals Private Limited (Director, since 15 Jul 2014, revenue ₹25.09 Cr (FY 2025)); Gelmek Healthcare Private Limited (Director, since 11 Sep 2018, revenue ₹9.92 Cr (FY 2025)); Eurus Lifesciences Llp (Designated Partner, since 08 Dec 2017, revenue ₹1.37 Cr (FY 2021)); Favion Healthcare Private Limited (Director, since 25 Apr 2025); Euraphor Lifesciences Private Limited (Director, since 04 Jul 2024).

Bhavik Jain was first appointed on 15 Jul 2014 as Director at Fitwel Pharmaceuticals Private Limited. The most recent appointment on record is 25 Apr 2025 at Favion Healthcare Private Limited.

The 3 current companies of Bhavik Jain that report revenue have a combined latest revenue of ₹36.38 Cr: Fitwel Pharmaceuticals Private Limited ₹25.09 Cr (FY 2025); Gelmek Healthcare Private Limited ₹9.92 Cr (FY 2025); Eurus Lifesciences Llp ₹1.37 Cr (FY 2021).

The current boards of Bhavik Jain's companies include Bhupendra Kumar Jain (Fitwel Pharmaceuticals Private Limited), Chandra Kant Jain (Fitwel Pharmaceuticals Private Limited), Krutika Jain (Fitwel Pharmaceuticals Private Limited), Kshitij Jain (Fitwel Pharmaceuticals Private Limited), Arupee Sharan Gupta (Gelmek Healthcare Private Limited), Karan Rijhwani (Gelmek Healthcare Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available